At the end of June, three more major exhibitions that attract high attendances from the fine and speciality chemicals and which were due to take place in the autumn, were cancelled or postponed to 2021 due to the Covid-19 pandemic: CPhI Worldwide, In-Cosmetics, ChemUK and Making Pharmaceuticals.
Via CA Clover Intermediate II Investments, private equity firm the Carlyle Group is to invest about $940 million in fresh equity capital for a 20% stake in Piramal Pharma, the healthcare subsidiary of Indian conglomerate Piramal Enterprises (PEL).
Nouryon has completed two recently announced advances: the acquisition of the carboxymethyl cellulose (CMC) business of J.M. Huber, including a manufacturing plant and advanced R&D facility located in Äänekoski, Finland; and doubling organic peroxides at its plant in Itupeva, Brazil.
Clariant has taken what exective chairman Hariold Kottmann (above) called “another significant step towards becoming a pure-play speciality chemical company”, by completing the sale of its Masterbatches business to PolyOne on 1 July.
Small molecule CDMO Cambrex is to spend $3.6 million to increase flexible drug substance manufacturing capacity by 6 m3 (25%) at Karlskoga, Sweden, in response to growing demand for commercial-scale API manufacturing.
Bayer has made a series of agreements that, it said, “will substantially resolve” major outstanding Monsanto litigation at a cost it up to $5 billion in 2020, the same in 2021 and any more outstanding amounts in 2022. These have been unanimously approved by its board.
In a Q2 trading update, Solvay revealed that an impairment review is under way and likely to lead to a non-cash impairment of about €1.5 billion. This is the result of “the deterioration in short and mid term economic performance due to Covid-19,” the company said.
According to the American Chemistry Council’s (ACC) Mid-Year 2020 Chemical Industry Situation & Outlook, chemical volumes will contract by 9.3% this year, while shipments will decline by 13.5% on the back of a shrinking GDP and demand in key end use industries.
Current Issue
At the end of June, three more major exhibitions that attract high attendances from the fine and speciality
Via CA Clover Intermediate II Investments, private equity firm the Carlyle Group is to invest about $940 mi
Nouryon has completed two recently announced advances: the acquisition of the carboxymethyl cellulose (CMC)
Clariant has taken what exective chairman Hariold Kottmann (above) called “another significant ste
Most Popular
The European Chemicals Agency (ECHA) and the European Commission have announced plans to help EU member states and industry to address disinfectant shortages caused by the Covid-19 pandemic.
Roger-Marc Nicoud, CEO of Ypso-Facto, looks at the challenges and opportunities for CDMOs in the current crisis*
The current crisis has highlighted the dependence of European and, indeed, North American countries on delocalised production. This is the case for many goods, including APIs and drugs in general.
ChemChina and Sinochem have announced that they are consolidating their agricultural assets into a new holding company that will be called Syngenta Group.
